US meningitis outbreak death toll rises to 15

October 14, 2012

The death toll from an unprecedented US meningitis outbreak tied to a tainted steroid jumped to 15 after another person died from a fungal form of the disease, health authorities said Saturday.

The total number of cases stood at 198 across 13 states, the said on its website.

That figure includes 197 cases of and one case of a "peripheral joint infection," affecting joints such as the knees, hips, shoulders or elbows, the CDC said. Illinois also saw its first case included in the count.

Tennessee remains the hardest hit state with 52 cases and six deaths, followed by Michigan, with 41 cases and three deaths, and Virginia, with 34 cases and one death.

There have also been deaths in Indiana, Florida and Maryland.

Health officials say most of the 14,000 people in 23 states who may have received contaminated doses of the steroid—typically injected into the spine to treat back pain—have been notified.

But it could be weeks or even months before authorities have a final tally of the infections, due to the deadly 's long .

The rare strain of the disease, which inflames the protective membranes covering the brain and spinal cord, requires a lengthy hospital stay and intravenous anti-fungal medications. But meningitis is not contagious in this form.

The outbreak has led to calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.

Critics said have found a way to sidestep costly and strict oversight by classifying themselves as pharmacies, which are given freer rein to mix for patients.

US health officials launched an investigation after the first case was discovered in September, finding fungal contaminants in steroids produced by the New England Compounding Center.

The Massachusetts-based company subsequently issued a voluntary recall of all of its products and shut down all operations.

Deborah Autor, a deputy commissioner at the US Food and Drug Administration, launched an appeal Thursday to strengthen federal regulations for pharmaceutical compounding companies like NECC.

Lawmakers have said that they plan to propose bills to increase the regulatory power of the FDA, and a senator has asked for a criminal investigation to be opened.

Explore further: US tainted drug outbreak rises to 185 cases

Related Stories

US tainted drug outbreak rises to 185 cases

October 12, 2012
The number of people believed to have been sickened by a contaminated drug rose to 185 Friday, but US health officials said the death toll from the rare meningitis outbreak held steady at 14.

US warns meningitis cases could rise

October 12, 2012
US authorities have managed to contact most of the thousands of people exposed to the tainted drug blamed for a meningitis outbreak that has killed 14, but warned the number of infections could rise.

Tainted drug death toll rises to 14 in US

October 11, 2012
The death toll from a deadly meningitis outbreak in the United States blamed on a tainted drug rose to 14 Thursday as the number of cases jumped to 172 in 11 states, health officials said.

7 dead in spreading US meningitis outbreak

October 8, 2012
At least seven people have died and 91 have fallen ill in the United States in a worsening meningitis outbreak tied to a contaminated drug, updated figures showed Sunday.

US pharmacy linked to outbreak issues wide recall

October 7, 2012
(AP)—The pharmacy that distributed a steroid linked to an outbreak of fungal meningitis has issued a voluntary recall of all of its products, calling the move a precautionary measure.

US clinics rush to warn of tainted steroid; 5 dead

October 5, 2012
(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five people have died.

Recommended for you

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

A new class of drug to treat herpes simplex virus-1 infection

February 14, 2018
For patients with the herpes simplex-1 virus (HSV-1), there are just a handful of drugs available to treat the painful condition that can affect the eyes, mouth and genitals.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.